103 related articles for article (PubMed ID: 14748439)
1. No association between oxidative stress and IL-6 in NIDDM patients with nephropathy.
Alsancak S; Aydin M; Yildiz A; Salman S; Seçkin S
Folia Biol (Praha); 2003; 49(6):235-7. PubMed ID: 14748439
[TBL] [Abstract][Full Text] [Related]
2. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
[TBL] [Abstract][Full Text] [Related]
3. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
[TBL] [Abstract][Full Text] [Related]
5. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
Aso Y; Yoshida N; Okumura K; Wakabayashi S; Matsutomo R; Takebayashi K; Inukai T
Clin Chim Acta; 2004 Oct; 348(1-2):139-45. PubMed ID: 15369747
[TBL] [Abstract][Full Text] [Related]
6. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
[TBL] [Abstract][Full Text] [Related]
7. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233
[TBL] [Abstract][Full Text] [Related]
8. Familial factors in diabetic nephropathy: an offspring study.
Agius E; Attard G; Shakespeare L; Clark P; Vidya MA; Hattersley AT; Fava S
Diabet Med; 2006 Mar; 23(3):331-4. PubMed ID: 16492220
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy.
Cvetković T; Mitić B; Lazarević G; Vlahović P; Antić S; Stefanović V
J Diabetes Complications; 2009; 23(5):337-42. PubMed ID: 18358753
[TBL] [Abstract][Full Text] [Related]
10. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
11. [The total antioxidant capacity and low-molecular antioxidant concentration in plasma of type-2 diabetes patients with different stage of metabolic compensation and concomitant diabetic nephropathy].
Błaszczak R; Kujawski K; Kedziora-Kornatowska K; Kornatowski T; Kedziora J; Szadujkis-Szadurski L; Markuszewski L; Rysz J; Ertel D; Olszewski R
Pol Merkur Lekarski; 2005 Jan; 18(103):29-32. PubMed ID: 15859542
[TBL] [Abstract][Full Text] [Related]
12. Increased serum levels of interleukin-18 in patients with diabetic nephropathy.
Mahmoud RA; el-Ezz SA; Hegazy AS
Ital J Biochem; 2004 Jul; 53(2):73-81. PubMed ID: 15646011
[TBL] [Abstract][Full Text] [Related]
13. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy.
Agarwal R
BMC Nephrol; 2005 Nov; 6():13. PubMed ID: 16303055
[TBL] [Abstract][Full Text] [Related]
14. Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy.
Rinno H; Kuramoto T; Iijima T; Yagame M; Tomino Y
J Clin Lab Anal; 1996; 10(3):119-24. PubMed ID: 8731497
[TBL] [Abstract][Full Text] [Related]
15. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
Aslan M; Sabuncu T; Kocyigit A; Celik H; Selek S
Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):734-40. PubMed ID: 17321120
[TBL] [Abstract][Full Text] [Related]
16. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress.
Gupta A; Tripathi AK; Tripathi RL; Madhu SV; Banerjee BD
Indian J Biochem Biophys; 2007 Oct; 44(5):373-8. PubMed ID: 18341213
[TBL] [Abstract][Full Text] [Related]
18. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
Dave GS; Kalia K
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
[TBL] [Abstract][Full Text] [Related]
20. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
